POU2F2-mediated Upregulation of lncRNA PTPRG-AS1 Inhibits Ferroptosis in Breast Cancer Via miR-376c-3p/SLC7A11 Axis

References

• Fahad Ullah M . Breast cancer: current perspectives on the disease status. Adv. Exp. Med. Biol. 1152, 51–64 (2019).
   PubMed Web of Science ®Google Scholar
• Yin L , Duan JJ , Bian XW , Yu SC . Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 22(1), 61 (2020).
   PubMed Web of Science ®Google Scholar
• Kalimutho M , Parsons K , Mittal D , López JA , Srihari S , Khanna KK . Targeted therapies for triple-negative breast cancer: combating a stubborn disease. Trends Pharmacol. Sci. 36(12), 822–846 (2015).
   PubMed Web of Science ®Google Scholar
• Cao JY , Dixon SJ . Mechanisms of ferroptosis. Cell. Mol. Life Sci. 73(11–12), 2195–2209 (2016).
   PubMed Web of Science ®Google Scholar
• Dixon SJ , Lemberg KM , Lamprecht MR et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5), 1060–1072 (2012).
   PubMed Web of Science ®Google Scholar
• Li Z , Chen L , Chen C et al. Targeting ferroptosis in breast cancer. Biomarker Res. 8(1), 58 (2020).
   PubMed Web of Science ®Google Scholar
• Zou Y , Zheng S , Xie X et al. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nat. Commun. 13(1), 2672 (2022).
   PubMed Web of Science ®Google Scholar
• Timmerman LA , Holton T , Yuneva M et al. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 24(4), 450–465 (2013).
   PubMed Web of Science ®Google Scholar
• Stockwell BR , Jiang X . The chemistry and biology of ferroptosis. Cell Chem. Biol. 27(4), 365–375 (2020).
   PubMed Web of Science ®Google Scholar
• Imai H , Matsuoka M , Kumagai T , Sakamoto T , Koumura T . Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis. Curr. Top. Microbiol. Immunol. 403, 143–170 (2017).
   PubMed Web of Science ®Google Scholar
• Wang D , Wang Z , Zhang L , Sun S . LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5p. Transl. Oncol. 14(1), 100958 (2021).
   PubMed Web of Science ®Google Scholar
• Wu H , Liu A . Long non-coding RNA NEAT1 regulates ferroptosis sensitivity in non-small-cell lung cancer. J. Int. Med. Res. 49(3), 300060521996183 (2021).
   PubMed Web of Science ®Google Scholar
• Chen G , Zhang Z , Li Y , Wang L , Liu Y . LncRNA PTPRG-AS1 promotes the metastasis of hepatocellular carcinoma by enhancing YWHAG. J. Oncol. 2021, 3624306 (2021).
   PubMed Web of Science ®Google Scholar
• Ge R , Yang P , Wen B . Upregulation of long-noncoding RNA PTPRG-AS1 can predict the poor prognosis and promote migration and invasion in patients with osteosarcoma. Oncol. Lett. 21(6), 464 (2021).
   PubMed Web of Science ®Google Scholar
• Iranpour M , Soudyab M , Geranpayeh L et al. Expression analysis of four long noncoding RNAs in breast cancer. Tumour Biol. 37(3), 2933–2940 (2016).
   PubMedGoogle Scholar
• Jiang L , Yu X , Ma X et al. Identification of transcription factor-miRNA-lncRNA feed-forward loops in breast cancer subtypes. Comput. Biol. Chem. 78, 1–7 (2019).
   PubMed Web of Science ®Google Scholar
• Ren W , Ren J , Zhang N et al. CBX7 represses POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer. Biochem. Biophys. Res. Commun. 613, 12–18 (2022).
   PubMed Web of Science ®Google Scholar
• Zhang H , Zhang N , Liu Y et al. Epigenetic regulation of NAMPT by NAMPT-AS drives metastatic progression in triple-negative breast cancer. Cancer Res. 79(13), 3347–3359 (2019).
   PubMed Web of Science ®Google Scholar
• Andersen GB , Tost J . Circulating miRNAs as biomarker in cancer. Recent Res. Cancer Res. 215, 277–298 (2020).
   PubMedGoogle Scholar
• Zhao F , Zhong M , Pei W , Tian B , Cai Y . miR-376c-3p modulates the properties of breast cancer stem cells by targeting RAB2A . Exp. Ther. Med. 20(5), 68 (2020).
   PubMed Web of Science ®Google Scholar
• Volovat SR , Volovat C , Hordila I et al. MiRNA and lncRNA as potential biomarkers in triple-negative breast cancer: a review. Front. Oncol. 10, 526850 (2020).
   PubMed Web of Science ®Google Scholar
• Lang X , Green MD , Wang W et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11 . Cancer Discov. 9(12), 1673–1685 (2019).
   PubMed Web of Science ®Google Scholar
• Ge C , Cao B , Feng D et al. The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells. Sci. Rep. 7(1), 3791 (2017).
   PubMedGoogle Scholar
• Deng XX , Jiao YN , Hao HF , Xue D , Bai CC , Han SY . Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10/STAT3/PD-L1 signaling pathways. J. Ethnopharmacol. 274, 113978 (2021).
   PubMed Web of Science ®Google Scholar
• Zhou DD , Bai WQ , Zhai XT et al. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer. Military Med. Res. 8(1), 63 (2021).
   PubMed Web of Science ®Google Scholar
• Lyons TG . Targeted therapies for triple-negative breast cancer. Curr. Treat. Options Oncol. 20(11), 82 (2019).
   PubMed Web of Science ®Google Scholar
• Xu T , Ding W , Ji X et al. Molecular mechanisms of ferroptosis and its role in cancer therapy. J. Cell Mol. Med. 23(8), 4900–4912 (2019).
   PubMed Web of Science ®Google Scholar
• Bai T , Liang R , Zhu R , Wang W , Zhou L , Sun Y . MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells. J. Cell. Physiol. 235(7–8), 5637–5648 (2020).
   PubMed Web of Science ®Google Scholar
• Wang Y , Zhao M , Zhao L et al. HBx-induced HSPA8 stimulates HBV replication and suppresses ferroptosis to support liver cancer progression. Cancer Res. 83(7), 1048–1061 (2023).
   PubMed Web of Science ®Google Scholar
• Zhang H , Deng T , Liu R et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol. Cancer 19(1), 43 (2020).
   PubMed Web of Science ®Google Scholar
• Xu Q , Zhou L , Yang G et al. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis. Cell Biol. Int. 44(11), 2344–2356 (2020).
   PubMed Web of Science ®Google Scholar
• Xue Y , Diao M , Lyu J et al. Long noncoding RNAs PTPRG antisense RNA 1 targets cyclin D1 to facilitate cell proliferation in lung adenocarcinoma. Cancer Biother. Radiopharm. doi:10.1089/cbr.2021.0168 (2021).
   Web of Science ®Google Scholar
• He GN , Bao NR , Wang S , Xi M , Zhang TH , Chen FS . Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1/miR-214-3p/GPX4. Drug Design Dev. Ther. 15, 3965–3978 (2021).
   PubMed Web of Science ®Google Scholar
• Wang M , Mao C , Ouyang L et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Diff. 26(11), 2329–2343 (2019).
   PubMed Web of Science ®Google Scholar
• Luo W , Wang J , Xu W et al. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell Death Dis. 12(11), 1043 (2021).
   PubMed Web of Science ®Google Scholar
• Niu Y , Bao L , Chen Y et al. HIF2-induced long noncoding RNA RAB11B-AS1 promotes hypoxia-mediated angiogenesis and breast cancer metastasis. Cancer Res. 80(5), 964–975 (2020).
   PubMed Web of Science ®Google Scholar
• Jia X , Shi L , Wang X et al. KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation. Cell Death Dis. 10(5), 373 (2019).
   PubMed Web of Science ®Google Scholar
• Yang J , Guo Q , Wang L , Yu S . POU domain class 2 transcription factor 2 inhibits ferroptosis in cerebral ischemia reperfusion injury by activating sestrin2. Neurochem. Res. doi:10.1007/s11064-022-03791-x (2022).
   Web of Science ®Google Scholar
• Liu P , Wang Z , Ou X et al. The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition. Mol. Cancer 21(1), 198 (2022).
   PubMed Web of Science ®Google Scholar
• Piasecka D , Braun M , Kordek R , Sadej R , Romanska H . MicroRNAs in regulation of triple-negative breast cancer progression. J. Cancer Res. Clin. Oncol. 144(8), 1401–1411 (2018).
   PubMed Web of Science ®Google Scholar
• Huo D , Clayton WM , Yoshimatsu TF , Chen J , Olopade OI . Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients. Oncotarget 7(34), 55231–55248 (2016).
   PubMedGoogle Scholar
• Yang Y , Tai W , Lu N et al. lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging 12(10), 9085–9102 (2020).
   PubMedGoogle Scholar
• Ma Q , Dai X , Lu W , Qu X , Liu N , Zhu C . Silencing long non-coding RNA MEG8 inhibits the proliferation and induces the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/NOTCH2 axis. Biochem. Biophys. Res. Commun. 556, 72–78 (2021).
   PubMed Web of Science ®Google Scholar
• Saliminejad K , Khorram Khorshid HR , Soleymani Fard S , Ghaffari SH . An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J. Cell. Physiol. 234(5), 5451–5465 (2019).
   PubMed Web of Science ®Google Scholar
• Kong X , Duan Y , Sang Y et al. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J. Cell. Physiol. 234(6), 9105–9117 (2019).
   PubMed Web of Science ®Google Scholar
• Koppula P , Zhuang L , Gan B . Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12(8), 599–620 (2021).
   PubMed Web of Science ®Google Scholar
• Wang Y , Yang L , Zhang X et al. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53. EMBO Rep. 20(7), e47563 (2019).
   PubMed Web of Science ®Google Scholar
• Yang J , Zhou Y , Xie S et al. Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J. Exp. Clin. Cancer Res. 40(1), 206 (2021).
   PubMed Web of Science ®Google Scholar
• Zhang Y , Guo S , Wang S et al. LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling. Ecotoxicol. Environ. Safety 220, 112376 (2021).
   PubMed Web of Science ®Google Scholar
• Yadav P , Sharma P , Sundaram S , Venkatraman G , Bera AK , Karunagaran D . SLC7A11/xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells. Cancer Lett. 522, 211–224 (2021).
   PubMed Web of Science ®Google Scholar
• Lu X , Kang N , Ling X , Pan M , Du W , Gao S . MiR-27a-3p promotes non-small cell lung cancer through SLC7A11-mediated-ferroptosis. Front. Oncol. 11, 759346 (2021).
   PubMedGoogle Scholar
• Seibt TM , Proneth B , Conrad M . Role of GPX4 in ferroptosis and its pharmacological implication. Free Radical Biol. Med. 133, 144–152 (2019).
   PubMed Web of Science ®Google Scholar
• Wang D , Wei G , Ma J et al. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. BMC Cancer 21(1), 645 (2021).
   PubMed Web of Science ®Google Scholar